Please use this identifier to cite or link to this item: http://repo.tma.uz/xmlui/handle/1/762
Full metadata record
DC FieldValueLanguage
dc.contributor.authorJurabaeva, Muxabbat-
dc.date.accessioned2024-12-26T13:06:20Z-
dc.date.available2024-12-26T13:06:20Z-
dc.date.issued2024-
dc.identifier.issn2181-7812-
dc.identifier.urihttp://repo.tma.uz/xmlui/handle/1/762-
dc.description.abstractTuberkulyoz kasalligi (sil) butun dunyo bo’ylab o’limning 10 ta asosiy sabablaridan biri bo’lib, butun dunyoda asosiy sog’liqni saqlash muammosi bo’lib qolmoqda [1,19]. JSST hisob-kitoblariga ko’ra, 2017 yilda sil kasalligidan 1,3 million kishi vafot etgan, 10 million kishi kasal bo’lgan: 5,8 million erkak, 3,2 million ayol va 1 million bola. (Global sil kasalligi hisoboti 2018). 2018-yilda 119 ta past va o‘rta daromadli mamlakatlarda moliyalashtirish 6,9 milliard AQSh dollariga yetdi, bu dunyoda qayd etilgan sil kasalligi holatlarining 97 foizi [16,17] ni tashkil qiladi, biroq zarur bo‘lgan mablag‘ 10,4 milliard AQSh dollarini tashkil etadi. Bu 3,5 milliard dollarlik moliyalashtirish bo’shlig’ini qoldiradi. O‘zbekiston 30 million aholiga ega va aholi jon boshiga yalpi milliy daromadi 1137 yevroni tashkil etadi, bu esa uni o‘rta va o‘rta daromaddan pastroq mamlakatga aylantiradien_US
dc.relation.ispartofseries№ 8;-
dc.subjectsil kasalligi, uyda shifoxona, ambulator davolanish, davolash samaradorligi, davolashni tashkil etish, epidemik vaziyaten_US
dc.titleO‘pka tuberkulyozi kasalligini davolash modellarining qiyosiy xarakteristikalarien_US
dc.typeArticleen_US
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
06_O‘pka_tuberkulyozi_kasalligini_davolash_modellarining_qiyosiy.pdf1.4 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.